SciSparc acquires controlling stake in Neurothera Labs in asset deal
PositiveFinancial Markets

SciSparc has successfully acquired a controlling stake in Neurothera Labs, marking a significant step in its growth strategy. This acquisition is important as it enhances SciSparc's portfolio in the biotech sector, potentially leading to innovative developments in therapeutic solutions. The deal reflects confidence in Neurothera Labs' capabilities and aligns with SciSparc's mission to advance healthcare technologies.
— Curated by the World Pulse Now AI Editorial System






